4-Methylmorpholine → (+/-)-1-[3-(Benzhydrylidene-amino)-4-cyano-benzyl]-4-[(5-chloro-thiophen-2-yloxy)-acetyl]-6-oxo-piperazine-2-carboxylic acid methyl ester

HRID 1433020ノート

反応式

HRID 1433020 の反応式
[CH3:1][O:2][C:3]([CH:5]1[CH2:10][NH:9][CH2:8][C:7](=[O:11])[N:6]1[CH2:12][C:13]1[CH:18]=[CH:17][C:16]([C:19]#[N:20])=[C:15]([N:21]=[C:22]([C:29]2[CH:34]=[CH:33][CH:32]=[CH:31][CH:30]=2)[C:23]2[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=2)[CH:14]=1)=[O:4].[Cl:35][C:36]1[S:40][C:39]([O:41][CH2:42][C:43](O)=[O:44])=[CH:38][CH:37]=1.CN1CCOCC1.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F>CN(C=O)C.C(Cl)Cl.C([O-])(O)=O.[Na+]>[CH3:1][O:2][C:3]([CH:5]1[CH2:10][N:9]([C:43](=[O:44])[CH2:42][O:41][C:39]2[S:40][C:36]([Cl:35])=[CH:37][CH:38]=2)[CH2:8][C:7](=[O:11])[N:6]1[CH2:12][C:13]1[CH:18]=[CH:17][C:16]([C:19]#[N:20])=[C:15]([N:21]=[C:22]([C:23]2[CH:24]=[CH:25][CH:26]=[CH:27][CH:28]=2)[C:29]2[CH:34]=[CH:33][CH:32]=[CH:31][CH:30]=2)[CH:14]=1)=[O:4]

参加物

8

反応物 4

HCID 79724-MethylmorpholineHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 111831442-[(5-Chlorothiophen-2-yl)oxy]acetic acidHCID 54153171(+/-)-1-[3-(Benzhydrylidene-amino)-4-cyano-benzyl]-6-oxo-piperazine-2-carboxylic acid methyl ester

生成物 1

HCID 54009384(+/-)-1-[3-(Benzhydrylidene-amino)-4-cyano-benzyl]-4-[(5-chloro-thiophen-2-yloxy)-acetyl]-6-oxo-piperazine-2-carboxylic acid methyl ester収率 92%

試薬・触媒・溶媒 3

HCID 6228Dimethylformamide溶媒HCID 6344Dichloromethane溶媒HCID 516892Sodium Bicarbonate溶媒

実験手順

To a solution containing (±)-1-[3-(benzhydrylidene-amino)-4-cyano-benzyl]-6-oxo-piperazine-2-carboxylic acid methyl ester (1.17 g, 2.6 mmol), EXAMPLE 784, Part B, 5-chlorothiophen-2-yloxyacetic acid (0.5 g, 2.6 mmol), EXAMPLE 24, and N-methylmorpholine (0.58 g, 5.72 mmol) in anhydrous DMF (10 mL) is added HATU (1.09 g, 2.86 mmol) at ambient temperature. After 1.5 h, the reaction mixture is diluted with CH2Cl2 (100 mL) and aqueous NaHCO3 (100 mL) and the layers are separated. The aqueous phase is washed four times with CH2Cl2 (100 mL) and the combined organic phase is washed once with brine, dried over anhydrous Na2SO4, filtered and concentrated. The crude amide is purified by flash silica gel chromatography (hexane/EtOAc, 4:1 to 1:2) to afford 1.5 g of the title compound which is used directly in the next reaction. 1H NMR (300 MHz, CDCl3, ˜2:1 mixture of rotomers) major rotomer: δ3.55 (d, J=15.2 Hz, 1H), 3.60 (m, 1H), 3.69 (m, 5H), 4.37 (d, J=17.7 Hz, 1H), 4.62 (m, 2H), 4.79 (d, J=13.3 Hz, 1H), 5.35 (d, J=15.2 Hz, 1H), 6.05 (d, J=3.9 Hz, 1H), 6.52 (m. 2H), 6.84 (d, J=8.1 Hz, 1H), 7.18-7.49 (m, 11H), 7.76 (m, 1H) ppm; MS (ISP loop): m/z 627 (M+H).

後処理

  1. customthe layers are separated
  2. washThe aqueous phase is washed four times with CH2Cl2 (100 mL)
  3. washthe combined organic phase is washed once with brine
  4. dry with materialdried over anhydrous Na2SO4
  5. filtrationfiltered
  6. concentrationconcentrated
  7. customThe crude amide is purified by flash silica gel chromatography (hexane/EtOAc, 4:1 to 1:2)

出典と根拠

ORDレコード
ord-9e2bb215ffcc42a0bac4a9a95e2443cc
出典データセット
uspto-grants-2009_11
特許番号
US07612075B2

反応ノート

読み込み中…